Vaxart Inc is a trailblazing biotech firm focused on revolutionizing vaccines by making them available in oral tablet form, rather than traditional injections. This innovative approach is being applied to a range of infectious diseases, including norovirus, seasonal influenza, respiratory syncytial virus, coronavirus, and human papillomavirus (HPV), with several vaccines currently undergoing clinical trials. Based in South San Francisco, California, Vaxart's mission is to enhance vaccine accessibility and acceptance worldwide.